Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-15
2006-08-15
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S236200, C514S375000, C514S376000, C540S467000, C544S137000, C548S218000, C548S229000, C548S232000
Reexamination Certificate
active
07091196
ABSTRACT:
The invention provides a family of compounds useful as anti-infective agents and/or anti-proliferative agents, for example, chemotherapeutic agents, anti-fungal agents, anti-bacterial agents, anti-parasitic agents, anti-viral agents, and/or anti-inflammatory agents, and/or prokinetic (gastrointestinal modulatory) agents, having the formula:or pharmaceutically acceptable salts, esters, or prodrugs thereof.
REFERENCES:
patent: 3629232 (1971-12-01), Jones
patent: 3681325 (1972-08-01), Freiberg
patent: 4404201 (1983-09-01), Haskell et al.
patent: 4546176 (1985-10-01), Machida et al.
patent: 5180719 (1993-01-01), White et al.
patent: 5232918 (1993-08-01), Arnould et al.
patent: 5281703 (1994-01-01), White et al.
patent: 5336768 (1994-08-01), Albrecht et al.
patent: 5444051 (1995-08-01), Agouridas et al.
patent: 5527780 (1996-06-01), Agouridas et al.
patent: 5543400 (1996-08-01), Agouridas et al.
patent: 5658888 (1997-08-01), Koga et al.
patent: 5693791 (1997-12-01), Truett
patent: 5747467 (1998-05-01), Agouridas et al.
patent: 5780605 (1998-07-01), Or et al.
patent: 5866549 (1999-02-01), Or et al.
patent: 5891643 (1999-04-01), Fesik et al.
patent: 5905144 (1999-05-01), Truett
patent: 5955440 (1999-09-01), Sauer et al.
patent: 6020521 (2000-02-01), Randolph et al.
patent: 6034069 (2000-03-01), Or et al.
patent: 6274715 (2001-08-01), Or et al.
patent: 6288055 (2001-09-01), Natarajan et al.
patent: 6288234 (2001-09-01), Griffin
patent: 6355805 (2002-03-01), Choi et al.
patent: 6355810 (2002-03-01), Griffin et al.
patent: 6362371 (2002-03-01), Moran et al.
patent: 6395724 (2002-05-01), Judice et al.
patent: 6420354 (2002-07-01), Marquess et al.
patent: 6437119 (2002-08-01), Truett
patent: 6446032 (2002-09-01), Schimmel
patent: 6468979 (2002-10-01), Pellacini et al.
patent: 6479498 (2002-11-01), Marquess et al.
patent: 6566509 (2003-05-01), Griffin et al.
patent: 6878691 (2005-04-01), Or et al.
patent: 2002/0028943 (2002-03-01), Griffin
patent: 2003/0158093 (2003-08-01), Sun et al.
patent: 2003/0176670 (2003-09-01), Griffin et al.
patent: 2003/0176848 (2003-09-01), Gibson et al.
patent: 2003/0181399 (2003-09-01), Wong et al.
patent: 2003/0212010 (2003-11-01), Phan et al.
patent: 2004/0014685 (2004-01-01), Mercep et al.
patent: 2004/0077612 (2004-04-01), Mercep et al.
patent: 2004/0097434 (2004-05-01), Mercep et al.
patent: 2004/0157787 (2004-08-01), Or et al.
patent: 196 04 223 (1997-08-01), None
patent: 0 215 355 (1994-04-01), None
patent: 0 213 617 (1994-08-01), None
patent: 0643068 (1998-08-01), None
patent: 0 680 967 (1998-10-01), None
patent: 0 895 999 (1999-02-01), None
patent: 1 132 392 (2001-09-01), None
patent: 1 201 649 (2002-05-01), None
patent: 1 201 655 (2002-05-01), None
patent: WO 92/17184 (1992-10-01), None
patent: WO 93/07154 (1993-04-01), None
patent: WO 93/24509 (1993-12-01), None
patent: WO 94/10185 (1994-05-01), None
patent: WO 95/07271 (1995-03-01), None
patent: WO 96/18633 (1996-06-01), None
patent: WO 97/35195 (1997-09-01), None
patent: WO 97/48713 (1997-12-01), None
patent: WO 98/56800 (1998-12-01), None
patent: WO 99/16779 (1999-04-01), None
patent: WO 99/22722 (1999-05-01), None
patent: WO 99/28308 (1999-06-01), None
patent: WO 99/63937 (1999-12-01), None
patent: WO 99/64416 (1999-12-01), None
patent: WO 99/64417 (1999-12-01), None
patent: WO 00/06606 (2000-02-01), None
patent: WO 00/21960 (2000-04-01), None
patent: WO 00/40589 (2000-07-01), None
patent: WO 00/77016 (2000-12-01), None
patent: WO 01/40222 (2001-06-01), None
patent: WO 01/42242 (2001-06-01), None
patent: WO 01/40238 (2001-08-01), None
patent: WO 01/58885 (2001-08-01), None
patent: WO 01/80863 (2001-11-01), None
patent: WO 01/81350 (2001-11-01), None
patent: WO 02/051855 (2002-07-01), None
patent: WO 02/060912 (2002-08-01), None
patent: WO 02/080841 (2002-10-01), None
patent: WO 02/081468 (2002-10-01), None
patent: WO 02/081469 (2002-10-01), None
patent: WO 02/081470 (2002-10-01), None
patent: WO 02/096890 (2002-12-01), None
patent: WO 02/096916 (2002-12-01), None
patent: WO 03/022824 (2003-03-01), None
patent: WO 03/035073 (2003-05-01), None
patent: WO 03/035648 (2003-05-01), None
patent: WO 03/042228 (2003-05-01), None
patent: WO 03/070173 (2003-08-01), None
patent: WO 03/070174 (2003-08-01), None
patent: WO 03/070254 (2003-08-01), None
patent: WO 03/072575 (2003-09-01), None
patent: WO 2004/005309 (2004-01-01), None
patent: WO 2004/005310 (2004-01-01), None
patent: WO 2004/005313 (2004-01-01), None
patent: WO 2004/013153 (2004-02-01), None
patent: WO 2004/043984 (2004-05-01), None
patent: WO 2004/056817 (2004-07-01), None
patent: WO 2004/056818 (2004-07-01), None
patent: WO 2004/056819 (2004-07-01), None
patent: WO 2004/048392 (2004-08-01), None
patent: WO 04/080391 (2004-09-01), None
patent: WO 2004/078770 (2004-09-01), None
patent: WO 04/094449 (2004-11-01), None
patent: WO 04/096221 (2004-11-01), None
patent: WO 2005/042554 (2005-05-01), None
patent: WO 2005/049632 (2005-06-01), None
patent: WO 2005/085266 (2005-09-01), None
Phillips et al., Synthesis and Antibacterial Activity of 5-Substituted Oxazolidinones, Bioorganic and Medicinal Chemistry 11 (2003), pp. 35-41.
Costa et al. “Hybrids of macrolides and nucleobases or nucleosides” Tetrahedron Letters, vol. 41 (2000), pp. 3371-3375.
Denis et al. “Novel N-demethylation of ketolide : application to the solution phase parallel synthesis of n-desosaninyl-substituted ketolides using ion exchange resins” Tetrahedron Letters, vol. 43 (2002), pp. 4171-4174.
Faghih et al., “Synthesis of 9-Deoxo-4″-deoxy-6,9-epoxyerythromycin Derivatives: Novel and Acid-Stable Motilides,” J. Med. Chem, 41: 3402-3408 (1998).
Hwang et al. “1,3-Dipolar cycloaddition of nitrile oxides to 1-phenylsulfonyl-1,3-butadienes: synthesis of 3-(4,5-dihydroisoxazol-5-yl)pyrroles” Tetrahedron Lett., vol. 43 (2002), pp. 53-56.
Copy of International Search Report for International Application No. PCT/US03/30478, dated Jul. 13, 2004.
Akritopoulou-Zanze et al., “Synthesis and antibacterial activity of novel bifunctional macrolides,” Bioorganic & Medicinal Chemistry Letters xxx (2004) xxx-xxx, Available online www.sciencedirect.com.
Hanessian et al., “Quantamycin: A Computer-Simulated New-Generation Inhibitor of Bacterial Ribosomal Binding,”J. Am. Chem. Soc., 106:6114-6115 (1984).
Hecker et al., “Application of Hygromycin a Structure Activity Relationships to the Antibiotic A201A,”Bioorganic&Medicinal Chemistry Letters, 3(2):295-298 (1993).
Holmes et al., “Novel Dimeric Penicillin Derived Inhibitors of HIV-1 Proteinase: Interaction with the Catalytic Asparates,”Bioorganic&Medicinal Chemistry Letters, 3(4):503-508 (1993).
Rao et al., “Tight Binding of a Dimeric Derivative of Vancomycin with Dimeric L-Lys-D-Ala-D-Ala,”J. Am Chem. Soc, 119:10286-10290 (1997).
Shuker et al., “Discovering High-Affinity Ligands for Proteins: SAR by NMR,”Science, 274 (5292):1531-1543 (2003).
Vince et al., “Chloramphenicol Binding Site with Analogues of Chloramphenicol and Puromycin,” Antimicrobial Agents and Chemotherapy, 8(4):439-443 (1975).
Wang et al., “Dimeric Aminoglycosides: Design, Synthesis and RNA Binding,”Bioorganic&Medicinal Chemistry Letters, 7(14):1951-1956 (1997).
Welch et al., “An Inhibitor of Ribosomal Peptidyl Transferase Using Transition-State Analogy,”Biochemistry, 34(2):pp. 385-390 (1995).
Zemlicka et al., “Sparsophenicol: A New Synthetic Hybrid Antibiotic Inhibiting Ribosomal Peptide Synthesis,”J. Med. Chem., 25:1123-1125 (1982).
Zemlicka et al., “Hybrids of Antibiotics Inhibiting Protein Synthesis. Synthesis and Biological Activity,”J. Med. Chem., 36:1239-1244 (1993).
Gregory et al.J. Med. Chem., 32:1673-1681 (1989).
Jones, P.H., and Powley, E.K, “Chemical Modifications of Erythromycin Antibiotics. 1.3′-De(dimethylamino)erythromycin A and B,” J. Org. Chem., 33:665-670 (1968).
Stenmark, Heather G., et al., “Biomimetic Synthesis
Abelson John N.
Bhattacharjee Ashoke
Duffy Erin M.
Farmer Jay J.
Goldberg Joel A.
Elrifi Ivor R.
Erlacher Heidi A.
Grazier Nyeemah
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Rib-X Pharmaceuticals, Inc.
LandOfFree
Bifunctional heterocyclic compounds and methods of making... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bifunctional heterocyclic compounds and methods of making..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bifunctional heterocyclic compounds and methods of making... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3668351